Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • CA-125 Antigen
  • Organoplatinum Compounds
  • Ovarian Neoplasms
  • Paclitaxel

abstract

  • Forassessing activity of therapy for ovarian cancer, these data show that precise 50% or 75% CA-125 response criteria are as sensitive as standard response criteria. We propose that they may be used as a measure of response in lieu of or in addition to standard response criteria in clinical trials involving epithelial ovarian cancer. Sensitivity is maintained whether patients are treated with platinum or paclitaxel.

publication date

  • February 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10080591

Additional Document Info

start page

  • 501

end page

  • 8

volume

  • 17

number

  • 2